COMMUNIQUÉS West-GlobeNewswire

Werewolf Therapeutics Announces WTX-124 Clinical Abstract Accepted for Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
24/04/2024
Company to present an update of its ongoing monotherapy and combination Phase 1/1b study of WTX-124 in advanced or metastatic solid tumors WATERTOWN, Mass., April 24, 2024 (GLOBE NEWSWIRE) -- Werewolf Therapeutics, Inc [...]
Coherus Announces Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
24/04/2024
REDWOOD CITY, Calif., April 24, 2024 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Coherus, Nasdaq: CHRS) today announced the first presentation of clinical data for CHS-114, a highly selective cytolytic anti-CCR8 [...]
Cue Biopharma to Present at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
24/04/2024
BOSTON, April 24, 2024 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively modulate disease-specific T cells [...]
ImPact Biotech to Present Interim Phase 3 Data from ENLIGHTED Study of Padeliporfin VTP in Low Grade UTUC at Upcoming Medical Conferences
24/04/2024
Preliminary results from Phase 3 ENLIGHTED study in low grade upper tract urothelial cancer (UTUC) to be presented at AUA and ASCO Trial design for Phase 1 study of Padeliporfin VTP in pancreatic ductal adenocarcinoma ( [...]
Immunocore announces upcoming presentation and posters at ASCO 2024
24/04/2024
Immunocore announces upcoming presentation and posters at ASCO 2024 Phase 1 expansion data in immune checkpoints pre-treated cutaneous melanoma for brenetafusp (IMC-F106C targeting PRAME) to be presented during oral [...]
Merus Announces Abstracts Accepted for Presentation at the 2024 ASCO Annual Meeting
24/04/2024
Petosemtamab in combination with pembrolizumab in 1L HNSCC initial interim clinical data selected for rapid oral session presentation MCLA-145 as monotherapy or in combination with pembrolizumab in solid tumors initial [...]
ALX Oncology Announces Two Evorpacept Abstracts Accepted for Poster Presentation at 2024 ASCO Annual Meeting
24/04/2024
SOUTH SAN FRANCISCO, Calif., April 24, 2024 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc., (“ALX Oncology” or “the Company”) (Nasdaq: ALXO), an immuno-oncology company developing therapies that block the CD47 immune [...]
CG Oncology to Unveil Encouraging Results on Cretostimogene in Combination with Pembrolizumab at ASCO 2024
24/04/2024
- Final results of CORE-001 Phase 2 trial of cretostimogene in combination with pembrolizumab for the treatment of BCG-unresponsive NMIBC - IRVINE, Calif., April 24, 2024 (GLOBE NEWSWIRE) -- CG Oncology, Inc. (NASDAQ: [...]
Clearday introduces digital assistants in residential communities
24/04/2024
San Antonio, TX, April 24, 2024 (GLOBE NEWSWIRE) -- Clearday (OTCQX CLRD) is pleased to announce its new line of digital assistants for use in residential communities and the Clearday Clubs. Digital assistants can [...]
Sometimes Legends Come in Small Packages
24/04/2024
TerrAscend Launches Legend Mini Pre-Roll Packs in New Jersey TORONTO, April 24, 2024 (GLOBE NEWSWIRE) -- TerrAscend Corp. ("TerrAscend" or the "Company") (TSX: TSND) (OTCQX: TSNDF), a leading North American cannabis [...]
Gain Therapeutics Announces Positive Results from the Single Ascending Dose (SAD) Part of the Phase 1 Clinical Trial of GT-02287, a Novel GCase-Targeting Small Molecule Therapy for GBA1 Parkinson’s Disease
24/04/2024
BETHESDA, Md., April 24, 2024 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company leading the discovery and development of the next generation of [...]
Spectral AI Names Erich Spangenberg CEO of its IP Focused Subsidiary and Explores Potential Spin-Off of that Subsidiary
24/04/2024
Spangenberg brings significant IP monetization experience and the potential to unlock additional value for Spectral AI shareholders DALLAS, April 24, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral [...]
Helius Medical Technologies, Inc. Expands Stroke Clinical Program with Participation of Shepherd Center
24/04/2024
-- Helius Medical and Shepherd Center partner on a study that aims at rehabilitating walking mobility in people recovering from stroke -- -- Shepherd Center, a top neurorehabilitation hospital, is the third site in [...]
Eko2o S.A.S., a Majority-Controlled Subsidiary of MedCana/SFWJ Advances as Leading Infrastructure Supplier for Colombia’s Top Flower Producers
24/04/2024
Collaboration with Danziger International is also enhanced as company’s global footprint expands AUSTIN, Texas, April 24, 2024 (GLOBE NEWSWIRE) -- via IBN – Eko2o S.A.S., a pioneering force in agricultural technology [...]
Capricor Therapeutics Announces Positive Type-B Meeting with FDA for CAP-1002 Program for Duchenne Muscular Dystrophy
24/04/2024
-Company Aligned with FDA on Demonstration of Non-Clinical Comparability; Allowing for Immediate Use of San Diego Manufacturing Facility- -FDA Feedback Supports Requests for a Pre-BLA Meeting and Subsequent Rolling BLA [...]
HeartSciences Announces Grant of Fundamental Patent by the European Patent Office Covering Assessment of Diastolic Function of the Heart Using AI-ECG
24/04/2024
Patent covers use of AI-ECG for any echo measure of diastolic function, which is crucial for heart screening and early detection of heart disease Southlake, Texas, April 24, 2024 (GLOBE NEWSWIRE) -- Heart Test [...]
Sharecare awarded three-year NCQA Accreditation for Case Management
24/04/2024
Accreditation for its complex case management capabilities complements Sharecare's existing three-year NCQA accreditations for Population Health Program and Wellness and Health Promotion ATLANTA, April 24, 2024 (GLOBE [...]
RenovaroCube to Acquire 100% Ownership of Cyclomics, Reinforcing Cutting-Edge Cancer Diagnostics Partnership
24/04/2024
LOS ANGELES and AMSTERDAM, April 24, 2024 (GLOBE NEWSWIRE) -- Renovaro Inc. (Nasdaq: RENB), a trailblazer in AI-driven early cancer diagnostics and therapeutics, and Cyclomics, a leader in ultra-sensitive 4th generation [...]
Verana Health Announces Launch of Qdata® Thyroid Eye Disease
24/04/2024
Expansive real-world dataset, comprising more than 250,000 de-identified patients, will help advance research and expedite therapy development for thyroid eye disease SAN FRANCISCO, April 24, 2024 (GLOBE NEWSWIRE) -- [...]

Pages